FDA Approved: HALOBETASOL PROPIONATE — Supplemental Application (Coral Way Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for halobetasol propionate filed by Coral Way Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Contact Dermatitis
• Lichen Simplex Chronicus
• Plaque Psoriasis
• Seborrheic Dermatitis

Drugs mentioned

• HALOBETASOL PROPIONATE (Halobetasol propionate)

Snippet

SUPPL AP for HALOBETASOL PROPIONATE (HALOBETASOL PROPIONATE)